Upgrade to SI Premium - Free Trial

Teva (TEVA) Launches Generic Version of Letairis Tablets in U.S.

May 1, 2019 3:02 PM
Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today announced the launch of a generic version of Letairis®1 (ambrisentan) Tablets, 5 mg ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News

Next Articles